Federated Hermes’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.44M Buy
728,494
+1,579
+0.2% +$7.45K 0.01% 822
2025
Q1
$3.34M Buy
726,915
+296
+0% +$1.36K 0.01% 811
2024
Q4
$3.48M Buy
726,619
+9,840
+1% +$47.1K 0.01% 805
2024
Q3
$3.36M Buy
716,779
+1,134
+0.2% +$5.32K 0.01% 815
2024
Q2
$4.04M Sell
715,645
-25
-0% -$141 0.01% 760
2024
Q1
$2.94M Sell
715,670
-102,357
-13% -$421K 0.01% 840
2023
Q4
$3.45M Sell
818,027
-83,482
-9% -$352K 0.01% 811
2023
Q3
$3.89M Sell
901,509
-132,819
-13% -$574K 0.01% 762
2023
Q2
$6.82M Sell
1,034,328
-10,449
-1% -$68.9K 0.02% 628
2023
Q1
$7.09M Buy
1,044,777
+240,859
+30% +$1.64M 0.02% 627
2022
Q4
$5.94M Buy
803,918
+310,073
+63% +$2.29M 0.02% 647
2022
Q3
$4.88M Buy
493,845
+8,564
+2% +$84.6K 0.01% 679
2022
Q2
$5.29M Sell
485,281
-53,261
-10% -$580K 0.01% 671
2022
Q1
$6.09M Sell
538,542
-4,122
-0.8% -$46.6K 0.01% 731
2021
Q4
$8.51M Sell
542,664
-5,228
-1% -$82K 0.02% 689
2021
Q3
$9.39M Buy
547,892
+35,225
+7% +$604K 0.02% 661
2021
Q2
$11M Buy
512,667
+7,036
+1% +$151K 0.02% 619
2021
Q1
$7.6M Buy
505,631
+41,106
+9% +$617K 0.01% 736
2020
Q4
$6.1M Buy
464,525
+2,515
+0.5% +$33K 0.01% 757
2020
Q3
$4.46M Buy
462,010
+203,873
+79% +$1.97M 0.01% 756
2020
Q2
$2.95M Buy
258,137
+15,067
+6% +$172K 0.01% 856
2020
Q1
$2.52M Buy
243,070
+138,973
+134% +$1.44M 0.01% 821
2019
Q4
$1.71M Sell
104,097
-362,810
-78% -$5.95M ﹤0.01% 1076
2019
Q3
$6.2M Buy
466,907
+233,680
+100% +$3.1M 0.02% 712
2019
Q2
$3.29M Sell
233,227
-21,867
-9% -$308K 0.01% 916
2019
Q1
$4.69M Buy
255,094
+121,038
+90% +$2.23M 0.01% 804
2018
Q4
$3.5M Buy
134,056
+133,264
+16,826% +$3.48M 0.01% 841
2018
Q3
$19K Buy
+792
New +$19K ﹤0.01% 1857
2017
Q4
Sell
-25,131
Closed -$450K 2225
2017
Q3
$450K Buy
+25,131
New +$450K ﹤0.01% 1381
2017
Q1
Sell
-70,961
Closed -$1.13M 2177
2016
Q4
$1.13M Buy
70,961
+65,059
+1,102% +$1.04M ﹤0.01% 1084
2016
Q3
$98K Buy
+5,902
New +$98K ﹤0.01% 1565
2015
Q2
Sell
-15,500
Closed -$144K 2075
2015
Q1
$144K Buy
15,500
+6,585
+74% +$61.2K ﹤0.01% 1552
2014
Q4
$128K Buy
+8,915
New +$128K ﹤0.01% 1554